AYTU BIOPHARMA, INC (AYTU) earnings date, results and what the price requires
Nasdaq · SEC CIK 0001385818 · SEC filings checked Oct 17, 2026
Next report
Dec 30, 2026
Estimated from reporting history (99-day cycle, SEC 8-K item 2.02 results filings). Not confirmed.
Last close
$2.01
Polygon.io daily close, Oct 15, 2026. End of day, not live.
Trailing diluted EPS
—
Needs four consecutive reported quarters.
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Jun 30, 2026 | Sep 22, 2026 | $16.1M | $-15,000 | — | Filing |
| Mar 31, 2026 | May 13, 2026 | $12.4M | $-5.6M | $-0.53 | Filing |
| Dec 31, 2025 | Feb 3, 2026 | $15.2M | $-10.6M | $-1.05 | Filing |
| Sep 30, 2025 | Nov 13, 2025 | $13.9M | $2.0M | $-0.08 | Filing |
| Jun 30, 2025 | Sep 23, 2025 | $15.1M | $-19.8M | — | Filing |
| Mar 31, 2025 | May 14, 2025 | $18.5M | $4.0M | $0.21 | Filing |
| Dec 31, 2024 | Feb 12, 2025 | $16.2M | $788,000 | $-0.26 | Filing |
| Sep 30, 2024 | Nov 13, 2024 | $16.6M | $1.5M | $-0.15 | Filing |
What would AYTU BIOPHARMA, INC have to report for its valuation to change?
Four consecutive reported quarters of diluted EPS are not available in SEC filings. The model is not shown rather than filled with assumptions.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.